Literature DB >> 30671687

Rapid increase in endometrial cancer incidence and ethnic differences in New Zealand.

Oliver W Scott1, Sandar Tin Tin2, Susan M Bigby3, J Mark Elwood2.   

Abstract

PURPOSE: Endometrial cancer accounts for 3.9% of all female cancers globally, and its incidence appears to be increasing in women under 40 years of age. This paper investigated ethnic-specific trends in endometrial cancer across different age groups in New Zealand.
METHODS: Women who were diagnosed with endometrial cancer between 1996 and 2012 were identified from the New Zealand Cancer Registry. Annual age-standardized incidence and mortality rates were calculated for each ethnicity (Māori, Pacific, and non-Māori non-Pacific) in four age groups (< 40, 40-49, 50-74, and 75 +). The estimates were adjusted for hysterectomy. Joinpoint regression analysis was used to assess trends over time and annual percentage changes (APCs) were estimated.
RESULTS: Between 1996 and 2012, age-standardized incidence rates increased in all women and significantly in the < 40, 40-49, and 50-74 age groups (APC 9.22, 3.56, and 1.65 respectively). Incidence rates were highest in Pacific women and increased most rapidly in those under 50 years of age (APC 9.36). Conversely, age-standardized mortality rates decreased in all women and significantly in the 50-74 and 75 + age groups (APC - 5.25 and - 5.06 respectively), with the highest rate observed in Pacific women.
CONCLUSION: Pacific women had the highest incidence of endometrial cancer and the trend was increasing, particularly in young women. This could be attributed, at least in part, to a high and increasing rate of obesity in these women and should be explored in future research.

Entities:  

Keywords:  Endometrial cancer; Incidence; New Zealand; Obesity; Pacific

Mesh:

Year:  2019        PMID: 30671687     DOI: 10.1007/s10552-019-1129-1

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  8 in total

1.  CircRNA circ-ATAD1 is downregulated in endometrial cancer and suppresses cell invasion and migration by downregulating miR-10a through methylation.

Authors:  Pengxia Yang; Kunlun Yun; Ruying Zhang
Journal:  Mamm Genome       Date:  2021-08-18       Impact factor: 2.957

2.  Metabolic Syndrome as a Risk Factor of Endometrial Cancer: A Nationwide Population-Based Cohort Study of 2.8 Million Women in South Korea.

Authors:  HyunA Jo; Se Ik Kim; Wenyu Wang; Aeran Seol; Youngjin Han; Junhwan Kim; In Sil Park; Juwon Lee; Juhwan Yoo; Kyung-Do Han; Yong Sang Song
Journal:  Front Oncol       Date:  2022-06-16       Impact factor: 5.738

3.  Global, Regional, and National Burden of Endometrial Cancer, 1990-2017: Results From the Global Burden of Disease Study, 2017.

Authors:  Shuang Zhang; Ting-Ting Gong; Fang-Hua Liu; Yu-Ting Jiang; Hui Sun; Xiao-Xin Ma; Yu-Hong Zhao; Qi-Jun Wu
Journal:  Front Oncol       Date:  2019-12-19       Impact factor: 6.244

Review 4.  Efficacy of the LNG-IUS for treatment of endometrial hyperplasia and early stage endometrial cancer: Can biomarkers predict response?

Authors:  Molly Dore; Sara Filoche; Kirsty Danielson; Claire Henry
Journal:  Gynecol Oncol Rep       Date:  2021-02-19

Review 5.  Incidence trends for twelve cancers in younger adults-a rapid review.

Authors:  Erica di Martino; Lesley Smith; Stephen H Bradley; Scott Hemphill; Judy Wright; Cristina Renzi; Rebecca Bergin; Jon Emery; Richard D Neal
Journal:  Br J Cancer       Date:  2022-02-07       Impact factor: 9.075

6.  Endometrial Cancer Detection Using a Cervical DNA Methylation Assay (MPap) in Women with Abnormal Uterine Bleeding: A Multicenter Hospital-Based Validation Study.

Authors:  Kuo-Chang Wen; Rui-Lan Huang; Lin-Yu Chen; Tzu-I Wu; Chien-Hsing Lu; Tang-Yuan Chu; Yu-Che Ou; Chen-Hsuan Wu; Shih-Tien Hsu; Dah-Ching Ding; Ling-Hui Chu; Chien-Wen Chen; Heng-Cheng Chang; Yu-Shu Liu; Hui-Chen Wang; Yu-Chun Weng; Po-Hsuan Su; Hao Lin; Hung-Cheng Lai
Journal:  Cancers (Basel)       Date:  2022-09-05       Impact factor: 6.575

Review 7.  Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal-Maternal Interface.

Authors:  Valentina Bruno; Giacomo Corrado; Denisa Baci; Benito Chiofalo; Maria Antonia Carosi; Livia Ronchetti; Emilio Piccione; Adriana Albini; Douglas M Noonan; Giulia Piaggio; Enrico Vizza
Journal:  Front Oncol       Date:  2020-03-12       Impact factor: 6.244

8.  Beyond the numbers-understanding women's experiences of accessing care for abnormal uterine bleeding (AUB): a qualitative study.

Authors:  Claire Henry; Regina Jefferies; Alec Ekeroma; Sara Filoche
Journal:  BMJ Open       Date:  2020-11-17       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.